Source:http://linkedlifedata.com/resource/pubmed/id/14690007
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
2003-12-23
|
| pubmed:abstractText |
A 1-day workshop was conducted to gather interested Canadian radiation oncologists to identify priority research questions that could be answered through clinical trials under the auspices of the National Cancer Institute of Canada--Clinical Trials Group (NCIC-CTG) Symptom Control committee.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0936-6555
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
15
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
496-9
|
| pubmed:dateRevised |
2008-3-10
|
| pubmed:meshHeading | |
| pubmed:year |
2003
|
| pubmed:articleTitle |
A consensus development approach to define national research priorities in bone metastases: proceedings from NCIC CTG workshop.
|
| pubmed:affiliation |
Tom Baker Cancer Center, University of Calgary, Calgary, Canada. jacksonw@cancerboard.ab.ca
|
| pubmed:publicationType |
Congresses
|